Angiogenesis, Exudation, and Degeneration 2026 – Virtual Edition
February 7, 2026
Bascom Palmer Eye Institute invites you to join us in February 2026 for our 23rd annual angiogenesis meeting. This unique and exciting symposium entitled Angiogenesis, Exudation, and Degeneration 2026, will be held virtually on February 7, 2026. The program will feature an exceptional group of basic scientists, clinician scientists, and healthcare experts, all focused on understanding and treating neovascular, exudative, and degenerative diseases of the eye. The program will highlight the revolutionary therapies now in development and clinical practice for the management of non-exudative AMD, exudative AMD, diabetic retinopathy with and without macular edema, retinopathy of prematurity, and inherited retinal degenerations with a special emphasis on the present and future impact of these therapies on clinical practices.
COURSE DESCRIPTION
Angiogenesis 2026 follows the tradition of excellence established by Bascom Palmer’s widely acclaimed Angiogenesis programs between 2004 and 2025. Designed for retina specialists, general ophthalmologists, researchers, and industry, the current program will review the latest in imaging, translational research, and clinical trials with an emphasis on how these results will impact clinical ophthalmology. We will emphasize investigator-initiated research and recently completed clinical trials focused on the diagnosis and treatment of a wide range of retinal diseases with special emphasis on age-related macular degeneration, diabetic retinopathy, retinal vascular diseases, and inherited retinal degenerations.
For more information, email bpeicme@med.miami.edu.
CME Questions?
Contact Bascom Palmer Eye Institute Continuing Medical Education.